Development of Inward Leakage Standards for Half-Mask Air-Purifying Particulate Respirators, 54432-54434 [2013-21430]
Download as PDF
54432
Federal Register / Vol. 78, No. 171 / Wednesday, September 4, 2013 / Proposed Rules
Item name
Testing frequency, allowable leakage rates, and other requirements
(ii) USVs ..................................................
Tested quarterly, not to exceed 120 days. If the device does not function properly, or if a liquid leakage rate > 400 cubic centimeters per minute or a gas leakage rate > 15 cubic feet per minute is
observed, the valve must be removed, repaired and reinstalled, or replaced.
(iii) BSDVs ...............................................
Tested monthly, not to exceed 6 weeks. Valves must be tested for both operation and leakage. You
must test according to API RP 14H for SSVs (incorporated by reference as specified in § 250.198).
If a BSDV does not operate properly or if any fluid flow is observed during the leakage test, the
valve must be immediately repaired or replaced.
(iv) Electronic ESD logic ..........................
Tested monthly, not to exceed 6 weeks.
(v) Electronic ESD function .....................
Tested quarterly, not to exceed 120 days. Shut-in at least one well during the ESD function test. If
multiple wells are tied back to the same platform, a different well should be shut-in with each quarterly test.
[FR Doc. C1–2013–19861 Filed 9–3–13; 8:45 am]
BILLING CODE 1505–01–D
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
42 CFR Part 84
[Docket No. CDC–2013–0017; NIOSH–250]
Development of Inward Leakage
Standards for Half-Mask Air-Purifying
Particulate Respirators
Centers for Disease Control and
Prevention, HHS.
ACTION: Request for comment and notice
of public meeting.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces a public meeting concerning
inward leakage performance
requirements for the class of NIOSHcertified non-powered air-purifying
particulate respirators approved as halffacepiece respirators for protection from
particulate-only hazards. The purpose of
this meeting is to share information and
to seek stakeholder feedback, in
identified topic areas, concerning the
development of inward leakage
performance standards. Questions
concerning the identified topics of
specific interest are included in this
document. Attendance at the public
meeting is not required to submit
written responses to the questions in
this notice.
DATES: The public meeting will be held
September 17, 2013, 1:00 p.m.–5:00
p.m. ET, or after the last public
commenter has spoken. Stakeholder
comments to the questions included in
this document must be received by
11:59 p.m. ET on October 18, 2013.
ADDRESSES: Meeting location: Bruceton
Research Center, NIOSH National
Personal Protective Technology
tkelley on DSK3SPTVN1PROD with PROPOSALS
SUMMARY:
VerDate Mar<15>2010
18:08 Sep 03, 2013
Jkt 229001
Laboratory (NPPTL), 626 Cochrans Mill
Road, Building 140, Multi-purpose
Room, Pittsburgh, PA 15236. This
meeting will also be available by remote
access.
Written Comments: You may submit
comments by either of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
Columbia Parkway, Cincinnati, OH
45226.
Instructions: All submissions received
must include the agency name (Centers
for Disease Control and Prevention,
HHS) and docket number (CDC–2013–
0017; NIOSH–250). All relevant
comments, including any personal
information provided, will be posted
without change to https://
www.regulations.gov.
Docket: For access to the docket to
read background documents and
submitted comments, go to https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Colleen Miller, NIOSH National
Personal Protective Technology
Laboratory (NPPTL), 626 Cochrans Mill
Road, Pittsburgh, PA 15236 (412) 386–
4956 or (412) 386–5200 (these are not
toll free numbers).
SUPPLEMENTARY INFORMATION:
I. Background
Testing, quality control, and other
requirements under 42 CFR Part 84 are
intended to ensure that respirators
supplied to U.S. workers provide
effective protection when properly
employed within a complete respiratory
protection program, as specified under
MSHA and OSHA regulations. NIOSH
requirements governing approval of
half-mask air-purifying particulate
respirators, those defined in this notice,
are principally specified in Part 84,
under Subpart K—Non-Powered Air-
PO 00000
Frm 00032
Fmt 4702
Sfmt 4702
Purifying Particulate Respirators. The
performance of the respirator’s
facepiece-to-face seal and other
potential sources of inward leakage for
this type of respirator are important to
determine how much unfiltered
contaminated air the worker might
inhale. The facepiece-to-face seal
leakage can be substantial in the case of
a poorly fitting respirator. Effective fit
testing technology and procedures exist
to ensure that half-mask respirators
approved by NIOSH under Subpart K of
Part 84 have adequately performing
facepiece-to-face seals. The purpose of
this notice is to solicit stakeholder
feedback regarding standards for inward
leakage testing.
NIOSH believes that the employee is
more likely to achieve a good fit from
a respirator design that has been
demonstrated to achieve a specified
minimum level of performance during
certification testing. Accordingly,
NIOSH initiated rulemaking activities to
establish inward leakage performance
requirements for NIOSH-approved
particulate filtering respirators by
publishing a notice of proposed
rulemaking (NPRM) in the Federal
Register on October 30, 2009 [74 FR
56141]. The public comment period for
the rulemaking closed originally on
December 28, 2009 but was
subsequently extended upon request by
stakeholders to September 30, 2010.
Public meetings were held on December
3, 2009 and July 29, 2010 to allow
stakeholders to share feedback on the
proposed rule, including preliminary
results of their independently
completed or ongoing research. NIOSH
reviewed all comments submitted by
stakeholders and is considering them in
the development of a revised inward
leakage standard.
II. Test Panel History
Although NIOSH requires adequate
facepiece-to-face seals for other types of
respirators under Part 84, such
requirements have not been applied to
E:\FR\FM\04SEP1.SGM
04SEP1
Federal Register / Vol. 78, No. 171 / Wednesday, September 4, 2013 / Proposed Rules
the half-mask air-purifying particulate
respirators approved under subpart K. A
new test panel, based on the bivariate
distribution of face width and face
length, was developed by NIOSH in
2007, based on research completed in
2003.1 The bivariate panel was
developed following an anthropometric
survey of 3,997 respirator users to better
represent the U.S. civilian workforce by
weighting subjects to match the age and
race distribution of the U.S. population
as determined from the 2000 census. In
the rulemaking published in October
2009, NIOSH proposed to incorporate
the bivariate panel into the standard
testing procedures for inward leakage
testing of these respirators.2
In response to stakeholder comments,
specifically those addressing concerns
about the potential for inter-panel
variability when comparing panels
comprising different test subjects,
NIOSH researchers developed a peerreviewed protocol to investigate the
inter-panel variability. The study began
in July 2012 and was recently
completed. Data analysis is ongoing and
public webinars to share preliminary
results were held on July 23, 2013 and
August 20, 2013.3
During the inter-panel variability
study, potential issues with the
implementation of the proposed
performance requirement were carefully
considered by NIOSH leadership,
researchers, standard and policy
developers, and the technical experts
responsible for NIOSH certification
testing. This Federal Register notice
includes questions for stakeholders to
better understand and resolve potential
implementation issues.
tkelley on DSK3SPTVN1PROD with PROPOSALS
III. Public Meeting
NIOSH will hold a public meeting on
September 17, 2013 to discuss the
development of inward leakage
performance standards for the class of
NIOSH-certified, non-powered halffacepiece respirators approved under
the provisions of Subpart K of 42 CFR
Part 84. The format of the meeting will
be informal to encourage stakeholders to
share information and responses
regarding the information presented by
NIOSH, the questions included in this
notice, and any questions that may be
identified during the meeting.
1 Zhuang Z, Bradtmiller B, and Shaffer R.E. New
Respirator Fit Test Panels Representing the Current
U.S. Civilian Workforce. Journal of Occupational
and Environmental Hygiene 2007;4:647–659.
2 NIOSH. Total Inward Leakage Test for Halfmask Air-purifying Particulate Respirators.
Procedure No. RCT–APR–STP–0068. Available at
https://www.cdc.gov/niosh/docket/archive/pdfs/
NIOSH-137/0137-081209-DraftTIL.pdf.
3 Presentation slides for both webinars are found
in the dockets for this action.
VerDate Mar<15>2010
18:08 Sep 03, 2013
Jkt 229001
54433
This meeting will also be using
Audio/LiveMeeting Conferencing
remote access capabilities so that
interested parties may listen in and
view the presentations simultaneously
over the Internet. Parties remotely
accessing the meeting will have the
opportunity to comment during the
open comment period.
Registration is required for both inperson and video conferencing
participation. Because this meeting is
being held at a Federal site,
preregistration is required on or before
September 10, 2013 and a governmentissued photo ID will be required to
obtain entrance to the facility. Non-U.S.
citizens must register on or before
August 30, 2013 to allow sufficient time
for mandatory facility security clearance
procedures to be completed. Non-U.S.
citizens registered for another meeting
at the site on September 17, 2013, will
be considered to be registered for this
meeting. NIOSH encourages all others to
attend remotely.
An email confirming registration will
be sent from NIOSH for both in-person
participation and video conferencing
participation. Information regarding
participation via the video conferencing
will be provided in a separate email.
This option will be available to
participants on a first come, first served
basis.
Registration information is available
on the NIOSH NPPTL Web site at https://
www.cdc.gov/niosh/npptl/resources/
pressrel/letters/lttr-09172013.html.
(b) What other detection method for
ambient aerosol could be used? Provide
any supporting documents, references,
or data.
(c) Is corn oil an acceptable method
for evaluating N-series respirators (those
restricted to use in workplaces free of
oil aerosols) for certification purposes?
Why or why not? Are there issues
associated with corn oil degradation of
the media during the time required to
complete a typical OSHA fit test
protocol? Please explain your answer.
Would your concerns regarding the
effects of corn oil be eliminated if the
number of exposures to corn oil (i.e.,
repeated donnings) is limited? Please
explain your answer.
(d) What additional information or
issues should NIOSH consider regarding
the use of corn oil as an aerosol
challenge during performance testing for
filtering facepiece respirators? Please
include specific information that
supports your recommendation
including experiences, data, analyses,
studies, published articles, and standard
professional practices.
3. Should NIOSH allow the option of
multiple inward leakage test methods?
4. Should NIOSH define and establish
inward leakage standards for quartermasks? If you represent a respirator
manufacturer, do you currently market
quarter-mask respirators? If you are a
purchaser, do you currently use quartermask respirators? Please include a
description of the occupational use of
the quarter-mask respirators you are
manufacturing or using.
IV. Questions for Stakeholders
B. Subject Test Panels
1. What are the advantages and/or
disadvantages of using the NIOSH
bivariate panel in assessing the
facepiece-to-face seal as a regulatory
requirement for respirators?
(a) What are key implementation
issues you foresee and how do you
recommend addressing these issues?
(b) Would you support the use of
another panel, if so, which one (e.g., Los
Alamos National Laboratory (LANL)
full-facepiece panel, LANL halffacepiece panel 4)? Please explain your
answer.
2. Which panel(s) is your company
currently using to develop new
respirator models or to modify existing
respirators? Please identify or define the
panel (e.g., LANL full-facepiece, LANL
half-facepiece, NIOSH bivariate, or
Principal Component Analysis (PCA)),
A. Inward Leakage Performance
Standard Test Method
1. Which of the following test
method(s) would you recommend
including in the standard test procedure
for an inward leakage performance
standard test method: Condensation
nuclei counter (CNC) with differential
mobility analyzer with supplemental
aerosol, as needed; or general aerosol in
a chamber with a quantitative detection
method? Please provide your rationale
and information that supports your
recommendation including experiences,
data, analyses, studies, published
articles, and standard professional
practices.
2. In light of published data indicating
that particle penetration through the
filter media is negligible, in your
opinion, if the CNC method is used:
(a) Is the differential analyzer needed?
Explain why or why not, providing your
rationale and any supporting data or
information, including references or
sources of technical expert opinion.
PO 00000
Frm 00033
Fmt 4702
Sfmt 4702
4 Use of the LANL panels is established in
Procedure No. TEB–APR–STP–0005–05a–06,
Determination of Qualitative Isoamyl Acetate (IAA)
Facepiece Fit, Air-Purifying Respirators. Available
at https://www.cdc.gov/niosh/npptl/stps/pdfs/TEBAPR-STP-0005-05a-06.pdf.
E:\FR\FM\04SEP1.SGM
04SEP1
tkelley on DSK3SPTVN1PROD with PROPOSALS
54434
Federal Register / Vol. 78, No. 171 / Wednesday, September 4, 2013 / Proposed Rules
the number of test subjects generally
used, the distribution of the subjects
within the panel cells, the sizing basis,
and the representation of male and
female test subjects. What pass/fail
criteria are you currently using to
approve proto-types for further
development or production?
(a) As a manufacturer, do you use
facepiece-to-face seal criteria to qualify
a design for production? Please include
details about the criteria in your answer.
(b) As a purchaser, what are the
attributes you use to determine which
brand(s) or model(s) of respirators to
buy (e.g., price point, size, supplier,
availability)?
3. Does your company use a panel or
portion of a panel to develop respirators
for a defined user group (e.g., users with
smaller facial features, users with larger
facial features)? If so, please define the
user group, the panel used, the cells
included, and the number of subjects
generally needed.
(a) Could the LANL half-facepiece
panel be used to test respirators for
defined user groups? Please explain
why or why not and include related
implementation issues.
(b) What issues do you foresee in the
implementation of fit testing standards
for defined user groups?
4. Does your company use a panel or
a portion of a panel to ensure the quality
of a manufactured product line? If so,
what test method and panel are used?
How many subjects are included? Please
explain how you maintain your pool of
subjects.
5. NIOSH currently uses the LANL
half-facepiece panel (lip length, which
is actually the lip width, and face
length) for categorizing human subjects
to evaluate those half-mask respirators
evaluated for fit. What are the
advantages and/or disadvantages of
using the LANL half-facepiece panel for
an inward leakage requirement for halfmask air-purifying particulate
respirators, approved under subpart K,
which are currently not evaluated for
fit?
6. What panel size would be sufficient
for conducting a facepiece-to-face seal
certification test?
(a) Given the recommended number
of test subjects, should the pass/fail
criteria be specific and include a
minimum of one pass per member cell?
More than one per cell?
(b) Given the recommended number
of test subjects, should the pass/fail
criteria be panel based (e.g., 20/25, 28/
35) and not specific to panel cells?
(c) Should the pass/fail criteria
require an overall high pass rate and
allow for a percentage of failures or a
VerDate Mar<15>2010
18:08 Sep 03, 2013
Jkt 229001
lower fit factor pass criteria and a 100
percent pass rate?
C. Future Utility of the NIOSH Bivariate
Panel for All NIOSH-Approved
Respirators
1. Based on your experience with the
NIOSH bivariate panel, what
implementation issues must NIOSH
consider in order to use the NIOSH
bivariate panel for certification testing
of all classes of respirators?
2. Should NIOSH develop a second
NIOSH bivariate panel based on face
length and lip length? Please explain
why or why not and any
implementation concerns or specific
recommendations concerning future
implementation of a new panel utilizing
subject lip length and face length.
D. Inter-Panel Variability
1. What is an appropriate pass/fail
criterion? Assuming the CNC is used,
should the subject pass with a fit factor
of 20? 50? 75? 100?
2. If a corn oil chamber is used, what
inward leakage pass/fail criteria should
be used?
3. What other strategies do you
suggest to address the inter-panel
variability? Please provide specific
information that supports your
recommendation including experiences,
data, analyses, studies, published
articles, and standard professional
practices.
Dated: August 27, 2013.
Kathleen Sebelius,
Secretary.
[FR Doc. 2013–21430 Filed 9–3–13; 8:45 am]
BILLING CODE P
OFFICE OF PERSONNEL
MANAGEMENT
5 CFR Parts 300, 315, 335, 410, 537,
and 900
RIN 3206–AM77
Nondiscrimination Provisions
U.S. Office of Personnel
Management.
ACTION: Proposed rule.
AGENCY:
The Office of Personnel
Management (OPM) is proposing to
update various nondiscrimination
provisions appearing in title 5, Code of
Federal Regulations, to provide greater
consistency and reflect current law.
DATES: Comments must be received on
or before November 4, 2013.
ADDRESSES: Send or deliver comments
to U.S. Office of Personnel Management,
Office of Diversity & Inclusion, 1900 E
SUMMARY:
PO 00000
Frm 00034
Fmt 4702
Sfmt 4702
Street NW., Washington, DC 20415;
email to diversityandinclusion@
opm.gov; or fax to (202) 606–6042.
Comments may also be sent through the
Federal eRulemaking Portal at https://
www.regulations.gov. All submissions
received through the Portal must
include the agency name and docket
number or the Regulation Identifier
Number (RIN) for this rulemaking.
Please specify the section number for
each comment.
FOR FURTHER INFORMATION CONTACT:
Contact Sharon Wong by telephone at
(202) 606–7140; by TTY at 1–800–877–
8339; by fax at (202) 606–6042; or by
email at diversityandinclusion@
opm.gov.
SUPPLEMENTARY INFORMATION: Executive
Order 13563 directs agencies to promote
‘‘retrospective analysis of rules that may
be outmoded, ineffective, insufficient,
or excessively burdensome, and to
modify, streamline, expand, or repeal
them in accordance with what has been
learned.’’ Pursuant to that direction and
OPM’s plan for conducting retrospective
review (see https://www.opm.gov/Open/
Resources/RetrospectiveRegReview.pdf),
OPM has been reviewing a number of
existing regulations to determine
whether they should be changed or
eliminated.
Among the regulations OPM has
decided to review are those that contain
nondiscrimination provisions. OPM
chose these regulations for retrospective
review to further respond to a separate
instruction issued by President Obama
in a June 17, 2009, Memorandum on
Federal Benefits and
Nondiscrimination. That memorandum
directed OPM to issue guidance
‘‘regarding compliance with, and
implementation of, the civil service
laws, rules, and regulations, including 5
U.S.C. 2302(b)(10), which make it
unlawful to discriminate against Federal
employees or applicants for Federal
employment on the basis of factors not
related to job performance.’’ See
https://www.whitehouse.gov/the-pressoffice/memorandum-heads-executivedepartments-and-agencies-federalbenefits-and-non-discri.
Our review revealed that the
nondiscrimination provisions are
inconsistently worded and most have
not been updated to reflect recent legal
developments, including enactment of
the Genetic Information
Nondiscrimination Act of 2008 (GINA),
Pub. L. 110–233, which prohibits
discrimination on the basis of genetic
information. Accordingly, we are
issuing these proposed regulations to
update the nondiscrimination
provisions to reflect current law and to
E:\FR\FM\04SEP1.SGM
04SEP1
Agencies
[Federal Register Volume 78, Number 171 (Wednesday, September 4, 2013)]
[Proposed Rules]
[Pages 54432-54434]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-21430]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
42 CFR Part 84
[Docket No. CDC-2013-0017; NIOSH-250]
Development of Inward Leakage Standards for Half-Mask Air-
Purifying Particulate Respirators
AGENCY: Centers for Disease Control and Prevention, HHS.
ACTION: Request for comment and notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces a public meeting concerning inward leakage performance
requirements for the class of NIOSH-certified non-powered air-purifying
particulate respirators approved as half-facepiece respirators for
protection from particulate-only hazards. The purpose of this meeting
is to share information and to seek stakeholder feedback, in identified
topic areas, concerning the development of inward leakage performance
standards. Questions concerning the identified topics of specific
interest are included in this document. Attendance at the public
meeting is not required to submit written responses to the questions in
this notice.
DATES: The public meeting will be held September 17, 2013, 1:00 p.m.-
5:00 p.m. ET, or after the last public commenter has spoken.
Stakeholder comments to the questions included in this document must be
received by 11:59 p.m. ET on October 18, 2013.
ADDRESSES: Meeting location: Bruceton Research Center, NIOSH National
Personal Protective Technology Laboratory (NPPTL), 626 Cochrans Mill
Road, Building 140, Multi-purpose Room, Pittsburgh, PA 15236. This
meeting will also be available by remote access.
Written Comments: You may submit comments by either of the
following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS-C34, 4676 Columbia Parkway, Cincinnati, OH 45226.
Instructions: All submissions received must include the agency name
(Centers for Disease Control and Prevention, HHS) and docket number
(CDC-2013-0017; NIOSH-250). All relevant comments, including any
personal information provided, will be posted without change to https://www.regulations.gov.
Docket: For access to the docket to read background documents and
submitted comments, go to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Colleen Miller, NIOSH National
Personal Protective Technology Laboratory (NPPTL), 626 Cochrans Mill
Road, Pittsburgh, PA 15236 (412) 386-4956 or (412) 386-5200 (these are
not toll free numbers).
SUPPLEMENTARY INFORMATION:
I. Background
Testing, quality control, and other requirements under 42 CFR Part
84 are intended to ensure that respirators supplied to U.S. workers
provide effective protection when properly employed within a complete
respiratory protection program, as specified under MSHA and OSHA
regulations. NIOSH requirements governing approval of half-mask air-
purifying particulate respirators, those defined in this notice, are
principally specified in Part 84, under Subpart K--Non-Powered Air-
Purifying Particulate Respirators. The performance of the respirator's
facepiece-to-face seal and other potential sources of inward leakage
for this type of respirator are important to determine how much
unfiltered contaminated air the worker might inhale. The facepiece-to-
face seal leakage can be substantial in the case of a poorly fitting
respirator. Effective fit testing technology and procedures exist to
ensure that half-mask respirators approved by NIOSH under Subpart K of
Part 84 have adequately performing facepiece-to-face seals. The purpose
of this notice is to solicit stakeholder feedback regarding standards
for inward leakage testing.
NIOSH believes that the employee is more likely to achieve a good
fit from a respirator design that has been demonstrated to achieve a
specified minimum level of performance during certification testing.
Accordingly, NIOSH initiated rulemaking activities to establish inward
leakage performance requirements for NIOSH-approved particulate
filtering respirators by publishing a notice of proposed rulemaking
(NPRM) in the Federal Register on October 30, 2009 [74 FR 56141]. The
public comment period for the rulemaking closed originally on December
28, 2009 but was subsequently extended upon request by stakeholders to
September 30, 2010. Public meetings were held on December 3, 2009 and
July 29, 2010 to allow stakeholders to share feedback on the proposed
rule, including preliminary results of their independently completed or
ongoing research. NIOSH reviewed all comments submitted by stakeholders
and is considering them in the development of a revised inward leakage
standard.
II. Test Panel History
Although NIOSH requires adequate facepiece-to-face seals for other
types of respirators under Part 84, such requirements have not been
applied to
[[Page 54433]]
the half-mask air-purifying particulate respirators approved under
subpart K. A new test panel, based on the bivariate distribution of
face width and face length, was developed by NIOSH in 2007, based on
research completed in 2003.\1\ The bivariate panel was developed
following an anthropometric survey of 3,997 respirator users to better
represent the U.S. civilian workforce by weighting subjects to match
the age and race distribution of the U.S. population as determined from
the 2000 census. In the rulemaking published in October 2009, NIOSH
proposed to incorporate the bivariate panel into the standard testing
procedures for inward leakage testing of these respirators.\2\
---------------------------------------------------------------------------
\1\ Zhuang Z, Bradtmiller B, and Shaffer R.E. New Respirator Fit
Test Panels Representing the Current U.S. Civilian Workforce.
Journal of Occupational and Environmental Hygiene 2007;4:647-659.
\2\ NIOSH. Total Inward Leakage Test for Half-mask Air-purifying
Particulate Respirators. Procedure No. RCT-APR-STP-0068. Available
at https://www.cdc.gov/niosh/docket/archive/pdfs/NIOSH-137/0137-081209-DraftTIL.pdf.
---------------------------------------------------------------------------
In response to stakeholder comments, specifically those addressing
concerns about the potential for inter-panel variability when comparing
panels comprising different test subjects, NIOSH researchers developed
a peer-reviewed protocol to investigate the inter-panel variability.
The study began in July 2012 and was recently completed. Data analysis
is ongoing and public webinars to share preliminary results were held
on July 23, 2013 and August 20, 2013.\3\
---------------------------------------------------------------------------
\3\ Presentation slides for both webinars are found in the
dockets for this action.
---------------------------------------------------------------------------
During the inter-panel variability study, potential issues with the
implementation of the proposed performance requirement were carefully
considered by NIOSH leadership, researchers, standard and policy
developers, and the technical experts responsible for NIOSH
certification testing. This Federal Register notice includes questions
for stakeholders to better understand and resolve potential
implementation issues.
III. Public Meeting
NIOSH will hold a public meeting on September 17, 2013 to discuss
the development of inward leakage performance standards for the class
of NIOSH-certified, non-powered half-facepiece respirators approved
under the provisions of Subpart K of 42 CFR Part 84. The format of the
meeting will be informal to encourage stakeholders to share information
and responses regarding the information presented by NIOSH, the
questions included in this notice, and any questions that may be
identified during the meeting.
This meeting will also be using Audio/LiveMeeting Conferencing
remote access capabilities so that interested parties may listen in and
view the presentations simultaneously over the Internet. Parties
remotely accessing the meeting will have the opportunity to comment
during the open comment period.
Registration is required for both in-person and video conferencing
participation. Because this meeting is being held at a Federal site,
preregistration is required on or before September 10, 2013 and a
government-issued photo ID will be required to obtain entrance to the
facility. Non[hyphen]U.S. citizens must register on or before August
30, 2013 to allow sufficient time for mandatory facility security
clearance procedures to be completed. Non-U.S. citizens registered for
another meeting at the site on September 17, 2013, will be considered
to be registered for this meeting. NIOSH encourages all others to
attend remotely.
An email confirming registration will be sent from NIOSH for both
in-person participation and video conferencing participation.
Information regarding participation via the video conferencing will be
provided in a separate email. This option will be available to
participants on a first come, first served basis.
Registration information is available on the NIOSH NPPTL Web site
at https://www.cdc.gov/niosh/npptl/resources/pressrel/letters/lttr-09172013.html.
IV. Questions for Stakeholders
A. Inward Leakage Performance Standard Test Method
1. Which of the following test method(s) would you recommend
including in the standard test procedure for an inward leakage
performance standard test method: Condensation nuclei counter (CNC)
with differential mobility analyzer with supplemental aerosol, as
needed; or general aerosol in a chamber with a quantitative detection
method? Please provide your rationale and information that supports
your recommendation including experiences, data, analyses, studies,
published articles, and standard professional practices.
2. In light of published data indicating that particle penetration
through the filter media is negligible, in your opinion, if the CNC
method is used:
(a) Is the differential analyzer needed? Explain why or why not,
providing your rationale and any supporting data or information,
including references or sources of technical expert opinion.
(b) What other detection method for ambient aerosol could be used?
Provide any supporting documents, references, or data.
(c) Is corn oil an acceptable method for evaluating N-series
respirators (those restricted to use in workplaces free of oil
aerosols) for certification purposes? Why or why not? Are there issues
associated with corn oil degradation of the media during the time
required to complete a typical OSHA fit test protocol? Please explain
your answer. Would your concerns regarding the effects of corn oil be
eliminated if the number of exposures to corn oil (i.e., repeated
donnings) is limited? Please explain your answer.
(d) What additional information or issues should NIOSH consider
regarding the use of corn oil as an aerosol challenge during
performance testing for filtering facepiece respirators? Please include
specific information that supports your recommendation including
experiences, data, analyses, studies, published articles, and standard
professional practices.
3. Should NIOSH allow the option of multiple inward leakage test
methods?
4. Should NIOSH define and establish inward leakage standards for
quarter-masks? If you represent a respirator manufacturer, do you
currently market quarter-mask respirators? If you are a purchaser, do
you currently use quarter-mask respirators? Please include a
description of the occupational use of the quarter-mask respirators you
are manufacturing or using.
B. Subject Test Panels
1. What are the advantages and/or disadvantages of using the NIOSH
bivariate panel in assessing the facepiece-to-face seal as a regulatory
requirement for respirators?
(a) What are key implementation issues you foresee and how do you
recommend addressing these issues?
(b) Would you support the use of another panel, if so, which one
(e.g., Los Alamos National Laboratory (LANL) full-facepiece panel, LANL
half-facepiece panel \4\)? Please explain your answer.
---------------------------------------------------------------------------
\4\ Use of the LANL panels is established in Procedure No. TEB-
APR-STP-0005-05a-06, Determination of Qualitative Isoamyl Acetate
(IAA) Facepiece Fit, Air-Purifying Respirators. Available at https://www.cdc.gov/niosh/npptl/stps/pdfs/TEB-APR-STP-0005-05a-06.pdf.
---------------------------------------------------------------------------
2. Which panel(s) is your company currently using to develop new
respirator models or to modify existing respirators? Please identify or
define the panel (e.g., LANL full-facepiece, LANL half-facepiece, NIOSH
bivariate, or Principal Component Analysis (PCA)),
[[Page 54434]]
the number of test subjects generally used, the distribution of the
subjects within the panel cells, the sizing basis, and the
representation of male and female test subjects. What pass/fail
criteria are you currently using to approve proto-types for further
development or production?
(a) As a manufacturer, do you use facepiece-to-face seal criteria
to qualify a design for production? Please include details about the
criteria in your answer.
(b) As a purchaser, what are the attributes you use to determine
which brand(s) or model(s) of respirators to buy (e.g., price point,
size, supplier, availability)?
3. Does your company use a panel or portion of a panel to develop
respirators for a defined user group (e.g., users with smaller facial
features, users with larger facial features)? If so, please define the
user group, the panel used, the cells included, and the number of
subjects generally needed.
(a) Could the LANL half-facepiece panel be used to test respirators
for defined user groups? Please explain why or why not and include
related implementation issues.
(b) What issues do you foresee in the implementation of fit testing
standards for defined user groups?
4. Does your company use a panel or a portion of a panel to ensure
the quality of a manufactured product line? If so, what test method and
panel are used? How many subjects are included? Please explain how you
maintain your pool of subjects.
5. NIOSH currently uses the LANL half-facepiece panel (lip length,
which is actually the lip width, and face length) for categorizing
human subjects to evaluate those half-mask respirators evaluated for
fit. What are the advantages and/or disadvantages of using the LANL
half-facepiece panel for an inward leakage requirement for half-mask
air-purifying particulate respirators, approved under subpart K, which
are currently not evaluated for fit?
6. What panel size would be sufficient for conducting a facepiece-
to-face seal certification test?
(a) Given the recommended number of test subjects, should the pass/
fail criteria be specific and include a minimum of one pass per member
cell? More than one per cell?
(b) Given the recommended number of test subjects, should the pass/
fail criteria be panel based (e.g., 20/25, 28/35) and not specific to
panel cells?
(c) Should the pass/fail criteria require an overall high pass rate
and allow for a percentage of failures or a lower fit factor pass
criteria and a 100 percent pass rate?
C. Future Utility of the NIOSH Bivariate Panel for All NIOSH-Approved
Respirators
1. Based on your experience with the NIOSH bivariate panel, what
implementation issues must NIOSH consider in order to use the NIOSH
bivariate panel for certification testing of all classes of
respirators?
2. Should NIOSH develop a second NIOSH bivariate panel based on
face length and lip length? Please explain why or why not and any
implementation concerns or specific recommendations concerning future
implementation of a new panel utilizing subject lip length and face
length.
D. Inter-Panel Variability
1. What is an appropriate pass/fail criterion? Assuming the CNC is
used, should the subject pass with a fit factor of 20? 50? 75? 100?
2. If a corn oil chamber is used, what inward leakage pass/fail
criteria should be used?
3. What other strategies do you suggest to address the inter-panel
variability? Please provide specific information that supports your
recommendation including experiences, data, analyses, studies,
published articles, and standard professional practices.
Dated: August 27, 2013.
Kathleen Sebelius,
Secretary.
[FR Doc. 2013-21430 Filed 9-3-13; 8:45 am]
BILLING CODE P